BridgeBio Pharma
Duplicate source posts collapse into one event. Only direct subject-company stories are included in this public hub.
BridgeBio Pharma has reached an agreement with the US government to expand access to its drug Attruby under Medicaid and Medicare Part D. The deal does not include future pricing mandates.
Explore the exact intelligence modules available on every supported company page.
